NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia
NewGenIvf Group (NASDAQ: NIVF) has launched a new lifetime egg freezing service in Asia, offering a 'one charge, no worries' fertility preservation solution. The service allows customers to make a one-time payment for unlimited egg storage duration, targeting working women and professionals seeking reproductive flexibility.
The global egg freezing and embryo banking market, valued at $3.9 billion in 2022, is projected to grow at a 16.8% CAGR from 2023 to 2030. NewGen targets $12 million in annual revenue from this service in its first year. The launch aligns with increasing workplace benefits for fertility preservation and government support, such as Tokyo's metropolitan subsidy for egg freezing.
Market research shows particular interest from Chinese customers, with over 60% of surveyed women (predominantly aged 30-34) expressing interest in egg freezing services. Due to restrictions in China, these customers must seek international providers like NewGen.
NewGenIvf Group (NASDAQ: NIVF) ha lanciato un nuovo servizio di congelamento degli ovuli a lungo termine in Asia, offrendo una soluzione per la preservazione della fertilità con un 'unico pagamento, senza preoccupazioni'. Il servizio consente ai clienti di effettuare un pagamento una tantum per una durata illimitata di deposito degli ovuli, mirato a donne lavoratrici e professionisti che cercano flessibilità riproduttiva.
Il mercato globale del congelamento degli ovuli e della banca di embrioni, valutato 3,9 miliardi di dollari nel 2022, è previsto crescere a un CAGR del 16,8% dal 2023 al 2030. NewGen punta a 12 milioni di dollari di ricavi annuali da questo servizio nel suo primo anno. Il lancio è in linea con l'aumento dei benefici lavorativi per la preservazione della fertilità e il supporto governativo, come il sussidio metropolitano di Tokyo per il congelamento degli ovuli.
Le ricerche di mercato mostrano un particolare interesse da parte dei clienti cinesi, con oltre 60% delle donne intervistate (principalmente nella fascia di età 30-34) che esprimono interesse per i servizi di congelamento degli ovuli. A causa delle restrizioni in Cina, questi clienti devono cercare fornitori internazionali come NewGen.
NewGenIvf Group (NASDAQ: NIVF) ha lanzado un nuevo servicio de congelación de óvulos a largo plazo en Asia, ofreciendo una solución de preservación de la fertilidad con un 'pago único, sin preocupaciones'. El servicio permite a los clientes realizar un pago único para una duración ilimitada de almacenamiento de óvulos, dirigido a mujeres trabajadoras y profesionales que buscan flexibilidad reproductiva.
El mercado global de congelación de óvulos y banco de embriones, valorado en 3.9 mil millones de dólares en 2022, se proyecta que crezca a un CAGR del 16.8% de 2023 a 2030. NewGen tiene como objetivo 12 millones de dólares en ingresos anuales de este servicio en su primer año. El lanzamiento se alinea con el aumento de beneficios laborales para la preservación de la fertilidad y el apoyo gubernamental, como el subsidio metropolitano de Tokio para la congelación de óvulos.
Las investigaciones de mercado muestran un interés particular por parte de los clientes chinos, con más de 60% de las mujeres encuestadas (principalmente de 30 a 34 años) expresando interés en los servicios de congelación de óvulos. Debido a las restricciones en China, estos clientes deben buscar proveedores internacionales como NewGen.
NewGenIvf Group (NASDAQ: NIVF)는 아시아에서 평생 난자 동결 서비스가 시작되었으며, '한 번의 요금, 걱정 없음'이라는 불임 보존 솔루션을 제공합니다. 이 서비스는 고객이 무제한 난자 저장 기간에 대해 일회성 지불을 하도록 허용하며, 직장 여성과 생식 유연성을 원하는 전문가를 대상으로 합니다.
2022년 39억 달러로 평가된 세계 난자 동결 및 배아 은행 시장은 2023년부터 2030년까지 연평균 16.8% 성장할 것으로 예상됩니다. NewGen은 첫 해에 이 서비스에서 1200만 달러의 연간 수익을 목표로 하고 있습니다. 이 런칭은 난자 동결을 위한 직장 내 복리후생 증가 및 도쿄의 도시 보조금과 같은 정부 지원과 일치합니다.
시장 연구에 따르면 중국 고객의 특별한 관심이 나타나며, 조사에 응답한 여성의 60% 이상(주로 30-34세)가 난자 동결 서비스에 관심을 보였습니다. 중국의 제한으로 인해 이러한 고객들은 NewGen과 같은 국제 공급자를 찾아야 합니다.
NewGenIvf Group (NASDAQ: NIVF) a lancé un nouveau service de congélation d'ovules à vie en Asie, offrant une solution de préservation de la fertilité avec un 'paiement unique, sans souci'. Ce service permet aux clients d'effectuer un paiement unique pour une durée de stockage d'ovules illimitée, s'adressant aux femmes en activité et aux professionnels en quête de flexibilité reproductive.
Le marché mondial de la congélation d'ovules et de la banque d'embryons, évalué à 3,9 milliards de dollars en 2022, devrait croître à un CAGR de 16,8% de 2023 à 2030. NewGen vise 12 millions de dollars de revenus annuels provenant de ce service lors de sa première année. Ce lancement s'inscrit dans une tendance à l'augmentation des avantages en milieu de travail pour la préservation de la fertilité et le soutien gouvernemental, tel que le subside métropolitain de Tokyo pour la congélation d'ovules.
Les recherches de marché montrent un intérêt particulier de la part des clientes chinoises, avec plus de 60% des femmes interrogées (principalement âgées de 30 à 34 ans) exprimant de l'intérêt pour les services de congélation d'ovules. En raison des restrictions en Chine, ces clientes doivent se tourner vers des fournisseurs internationaux comme NewGen.
NewGenIvf Group (NASDAQ: NIVF) hat einen neuen lebenslangen Eizelleneinfrier-Service in Asien gestartet, der eine 'einmalige Gebühr, keine Sorgen'-Lösung zur Erhaltung der Fruchtbarkeit bietet. Der Service ermöglicht es Kunden, eine einmalige Zahlung für eine unbegrenzte Dauer der Eizelleneinlagerung zu leisten, und richtet sich an berufstätige Frauen und Fachkräfte, die reproduktive Flexibilität suchen.
Der globale Markt für Eizellen-Einfrierung und Embryobank, der 2022 auf 3,9 Milliarden Dollar geschätzt wurde, wird voraussichtlich mit einer Jahreswachstumsrate von 16,8% von 2023 bis 2030 wachsen. NewGen zielt darauf ab, im ersten Jahr 12 Millionen Dollar Jahresumsatz aus diesem Service zu erzielen. Der Launch ist Teil eines Trends zu mehr Arbeitsplatzvorteilen für die Erhaltung der Fruchtbarkeit und staatlicher Unterstützung, wie dem städtischen Zuschuss für Eizellen-Einfrierungen in Tokio.
Marktforschung zeigt ein besonderes Interesse seitens chinesischer Kunden, wobei über 60% der befragten Frauen (hauptsächlich im Alter von 30-34) Interesse an Eizelleneinfrier-Dienstleistungen bekunden. Aufgrund der Beschränkungen in China müssen diese Kunden internationale Anbieter wie NewGen suchen.
- Targeting $12 million annual revenue from new service in first year
- Entering market with 16.8% projected CAGR (2023-2030)
- Strong market potential from Chinese customers due to local restrictions
- Favorable regulatory environment with government subsidies in key markets
- Entering highly competitive market valued at $3.9 billion
- Success dependent on market penetration and customer acquisition
- Regulatory restrictions in key markets like China could affect growth
Insights
The launch of NewGen's lifetime egg freezing service represents a strategic market expansion into a rapidly growing sector. With the global egg freezing market projected at a 16.8% CAGR and a
The "one charge, no worries" model eliminates recurring storage fees, a significant pain point in traditional egg freezing services. This pricing innovation, combined with favorable demographic trends and increasing corporate benefits coverage, positions NewGen to capture substantial market share. The 60% interest rate among educated Chinese women aged 30-34 represents a particularly promising customer segment, especially given China's regulatory environment forcing customers to seek international options.
The strategic launch aligns with compelling market dynamics and presents significant revenue potential. The targeted
The market opportunity is particularly attractive given the regulatory arbitrage with China and growing government support, as evidenced by Tokyo's subsidy program. The service's positioning as a premium, lifetime solution should command higher margins compared to traditional pay-per-period models. The focus on high-value demographics - educated, professional women - suggests strong pricing power and customer lifetime value potential.
New service will address a significant market opportunity and grant new flexibility to women seeking reproductive flexibility
BANGKOK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the launch of its innovative lifetime egg freezing service in Asia. The innovative “one charge, no worries” fertility preservation solution is designed to serve the growing needs of women across Asia, and will allow customers to make a one-time payment to arrange for lifetime egg freezing.
NewGen’s new service addresses a robust market opportunity, particularly in light of increasing demand for egg freezing services in the region. The global egg freezing and embryo banking market, valued at US
NewGen aims to achieve significant market penetration for the service in its first year of operations, targeting annual revenue of US
NewGen plans to implement an integrated marketing strategy to build brand awareness and establish partnerships with key healthcare providers. Market research indicates particular strength from the Chinese market, where a research report on China’s assisted reproduction industry by a Beijing-based think tank found that over 60 percent of surveyed women, predominantly aged 30-34 and with higher education levels, expressed interest in egg freezing services. Existing restrictions on egg freezing in China means Chinese customers must turn to international providers such as NewGen for these services.
Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, “Our lifetime egg freezing service represents a transformative step forward in making fertility preservation more accessible and worry-free for women across Asia. We recognize that modern women, particularly those focused on their careers, are seeking greater flexibility and control over their reproductive choices. By removing the traditional storage time limits and offering a comprehensive lifetime service, we are addressing a crucial need in the market. Our research indicates strong demand, particularly among educated, professional women, and we believe we are positioned to become a leading provider of this essential service in the region.”
About NewGen
NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen’s management team collectively has over a decade of experience in the fertility industry. NewGen’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company’s future commercial operations, business strategy, and financial condition. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company’s ability to implement its business plans, identify and realize additional opportunities, meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company operates, or successfully launch new services or products. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company’s annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC’s website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: Newgenivf.IR@icrinc.com
FAQ
What is NewGen's (NIVF) revenue target for its new lifetime egg freezing service?
What is the projected CAGR for the egg freezing market where NIVF operates?
How large is the market opportunity for NIVF's egg freezing services?
What percentage of Chinese women are interested in NIVF's egg freezing services?
How does NewGen's (NIVF) lifetime egg freezing payment structure work?
